TROCKENEXTRAKT AUS PASSIONSBLUMENKRAUT 5-7:1, AUSZUGSMITTEL ETHANOL 60 % (V/V)

Clinical trials are studying TROCKENEXTRAKT AUS PASSIONSBLUMENKRAUT 5-7:1, AUSZUGSMITTEL ETHANOL 60 % (V/V) in patients having eye surgery. The trial aims to look at perioperative anxiety and pain, with a main focus on pain after a retrobulbar block. It includes people undergoing vitrectomy and/or cataract surgery.

Table of contents

Trial overview

The available trial investigates TROCKENEXTRAKT AUS PASSIONSBLUMENKRAUT 5-7:1, AUSZUGSMITTEL ETHANOL 60 % (V/V) in the setting of eye surgery.[1] Its brief summary says the study aims to investigate the effect of music on perioperative pain and the effect of herbal medicine on perioperative pain.[1]

The trial is titled “The effect of music on perioperative anxiety and pain of patients undergoing retrobulbar anaesthesia.”[1] This tells us the research is centered on anxiety and pain around the time of surgery, not on long-term disease treatment.[1]

Who can participate

The study includes patients undergoing vitrectomy and/or cataract surgery.[1] These are eye operations, so the target population is people scheduled for these procedures.[1]

The trial data do not list any other eligibility details, such as age limits or extra medical conditions.[1] Based on the source, the main known group is patients having eye surgery with retrobulbar anaesthesia.[1]

What is being measured

The main endpoint is the NRS-P score 30 seconds after the retrobulbar block.[1] An endpoint is the main result a trial measures to see whether the study question is answered.[1]

NRS-P is a pain rating score, so this trial is checking how much pain patients feel very soon after the block.[1] The trial also looks at perioperative anxiety and pain more broadly, based on the study title and summary.[1]

Study design and status

The study is listed as Interventional and Low Intervention.[1] Interventional means the researchers are testing a planned approach in participants, while Low Intervention suggests a lower-burden study design.[1]

The status is Authorised, and the planned enrollment is 240 participants.[1] Enrollment means the number of people the study aims to include.[1]

Patient terms explained

Perioperative anxiety means worry or nervousness before, during, or after surgery.[1] Perioperative pain means pain linked to the surgery period.[1]

A retrobulbar block is an injection used around the eye to numb it for surgery.[1] The study checks the pain score shortly after this block to understand the immediate patient experience.[1]

Vitrectomy and cataract surgery are eye operations, and both are part of the study population described in the trial record.[1] The source does not provide more detail on outcomes beyond the pain score and the anxiety/pain focus.[1]

Trial ID Phase Condition studied Status Enrollment
2024-520132-15-00 Low Intervention Patients undergoing vitrectomy and/or cataract surgery; perioperative anxiety and pain Authorised 240

Ongoing Clinical Trials on TROCKENEXTRAKT AUS PASSIONSBLUMENKRAUT 5-7:1, AUSZUGSMITTEL ETHANOL 60 % (V/V)

  • Study of herbal medicine combination and bromazepam for anxiety and pain in patients having eye surgery with retrobulbar anesthesia

    Recruiting

    3 1 1 1
    Investigated diseases:
    Austria

Glossary

  • Perioperative: The time before, during, and after surgery.
  • Anxiety: A feeling of worry, fear, or nervousness.
  • Pain score: A number used to show how strong pain is, usually reported by the patient.
  • NRS-P: A pain scale used in the trial to measure pain intensity.
  • Retrobulbar block: An injection used around the eye to numb it for surgery.
  • Vitrectomy: An eye operation that removes some or all of the vitreous gel from the eye.
  • Cataract surgery: An operation to remove a cloudy lens from the eye.
  • Interventional study: A study in which people receive a planned treatment or intervention.
  • Low Intervention: A study with a lower level of risk or burden for participants.
  • Enrollment: The number of people planned to join the study.

References

  1. https://clinicaltrials.gov/study/2024-520132-15-00